American Oncology Network (AONC) Stock Statistics & Valuation Metrics

American Oncology Network has a market cap or net worth of $472.49M. The enterprise value is $376.19M.

American Oncology Network has 32,129,753 shares outstanding. The number of shares has decreased by -2.65% in one year.

American Oncology Network’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -9.19%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, American Oncology Network had revenue of 1.76B and earned -3.97M in profits. Earnings per share was -0.29.

In the last 12 months, operating cash flow was 28.98M and capital expenditures -16.91M, giving a free cash flow of 12.07M billion.

American Oncology Network pays an annual dividend of ―, resulting in a dividend yield of ―

American Oncology Network upcoming earnings date is ―, ―.

American Oncology Network as a current ratio of 1.53, with Debt / Equity ratio of 785.08%

In the past 12 months, American Oncology Network has paid 2.50M in taxes.

American Oncology Network EV to EBITDA ratio is -8.83, with an EV/FCF ratio of -5.94.

American Oncology Network has $72.64M in cash and marketable securities with $147.37M in debt, giving a net cash position of $74.73M billion.

Gross margin is 6.70%, with operating margin of -0.99%, and net profit margin of -0.23%.

The average price target for American Oncology Network is $12.50, which is 11.43% higher than the current price. The consensus rating is Hold